In our current and future political debates about what to do about our expensive healthcare system (“sick care” system), we need to take a honest look at the large and growing public health issues that get in the way of truly addressing these issues. Water is just one of these subjects but a rather critical issue as there is no possibility for health and well being for anyone, whether rich or poor with unhealthy drinking water. The following peer reviewed study from The Environmental Working Group discusses cancer risk as well as a long list of known carcinogens found in drinking water across the US. “—the first study to conduct a cumulative assessment of cancer risks due to 22 carcinogenic contaminants found in drinking water nationwide.”
Peter Lupoff, Chief Executive Officer of Net Impact recently wrote a blog post discussing Bio-Ethics and Empathy as it relates to the divide between the rich and poor. One of the things I appreciated the most about this article was the very graphic vision regarding the dystopian future potential of ordinary people unless something changes. As we have discussed many times, the structure and incentives of our current economic system create these rather obscene imbalances. We need a completely new business and investment paradigm that is more holistic in nature and solves problems from a root cause level. At its core, this new system-based approach requires that we look honestly at the nature of the problem. In this article, a future that resembles a SciFi thriller is easy to imagine. It is a world where the ultra rich live long and healthy lives at the same time regular people, living in a business and financial world devoid of empathy, live in squalor. Fortunately, we do not have to imagine this future on our own. We have the movie “Elysium” with Matt Damon to assist us.
There is much discussion these days about how to “fix” healthcare with some of the brightest minds across disciplines working on this issue. What is truly amazing is how some of the most basic issues are not discussed at all. Every day we read about drug pricing, finding ways to switch to less expensive generic drugs… Reading all these articles, one would think the answer to all our healthcare problems starts and finishes with the pharmaceutical and biotechnology industries. I mean no disrespect to the brilliant scientists working on important, breakthrough treatments. I have spent most of my career analyzing and investing in novel science and technologies that solve important problems.[Read more…]
I made the decision recently to change the name of the business to Pythia Capital.
Who was Pythia?
Pythia was from ancient Greece and was a high priestess and oracle (also known as the Oracle of Delphi). According to Wikipedia, “The Pythia was established at the latest in the 8th century BC, and was widely credited for her prophecies inspired by being filled by the spirit of the god (or enthusiasmos), in this case Apollo. The Pythian priestess emerged pre-eminent by the end of 7th century BC and would continue to be consulted until the 4th century AD. During this period the Delphic Oracle was the most prestigious and authoritative oracle among the Greeks, and she was without doubt the most powerful woman of the classical world. The oracle is one of the best-documented religious institutions of the classical Greeks. Authors who mention the oracle include Aeschylus, Aristotle, Clement of Alexandria, Diodorus, Diogenes, Euripides, Herodotus, Julian, Justin, Livy, Lucan, Nepos, Ovid, Pausanias, Pindar, Plato, Plutarch, Sophocles, Strabo, Thucydides and Xenophon.”
Why did I change the name the company to Pythia Capital?
When reading about Pythia recently, I felt strong, powerful, confident, wise and more grounded. My cheeks felt warm and pink. I felt more energetic and joyful. “I am Pythia” I repeated to myself. As a woman in finance for many years, I can honestly say it took me a long time to get here personally and professionally. I am grateful to you Dear Pythia for the assistance and the reminder.
There are large amounts of capital flowing into areas such as digital healthcare and other services or products that claim to have the next big disruptive approach or innovation to solve important problems in healthcare. Based on the dollars flowing and the large return expectations that accompany this type of investment herd behavior, one would think we were close to big breakthroughs.
The author of this particular article, Lucienne Ide, CEO of Rimidi, discusses this subject honestly and effectively: